drugset / Trial / NCT03342807

Summary

To investigate an economical and effective way to reduce the level of serum triglyceride in patients with hypertriglyceridemia-induced acute pancreatitis.

Timeline

Start
2017-11
Primary completion
2019-11
Completion
2020-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 0.1 iu/kg Intravenous
Subject Insulin Protein / enzyme biologic 0.3 iu/kg Intravenous